Paresis following mechanical ventilation

Current Opinion in Critical Care

Volumn 10, Issue 1, 2004, Pages 47-52

  De Jonghe, Bernard ^a   Sharshar, Tarek ^b   Hopkinson, Nicholas ^b   Outin, Hervé ^a  

^a CENTRE HOSPITALIER INTERCOMMUNAL   (France)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Corticosteroids; Insulin; Intensive care unit; Mechanical ventilation; Neuromuscular abnormalities; Organ dysfunction; Paralysis

Indexed keywords

CORTICOSTEROID; GLUCOSE; INSULIN; NEUROMUSCULAR BLOCKING AGENT; SUXAMETHONIUM;

ARTIFICIAL VENTILATION; ASSOCIATION; BIOLOGICAL MONITORING; BREATHING; CARDIOPULMONARY INSUFFICIENCY; CLINICAL EXAMINATION; CLINICAL FEATURE; CORTICOSTEROID THERAPY; CRITICAL ILLNESS; DISEASE DURATION; DISEASE SEVERITY; GLUCOSE BLOOD LEVEL; HOSPITAL DISCHARGE; HUMAN; HYPERKALEMIA; INCIDENCE; INTENSIVE CARE UNIT; LIMB; MOTOR DYSFUNCTION; MULTIPLE ORGAN FAILURE; MUSCLE STRENGTH; MUSCLE WEAKNESS; NERVE FIBER; NEUROMUSCULAR DISEASE; PARESIS; REVIEW; RISK FACTOR; SCORING SYSTEM; SIDE EFFECT;

ADRENAL CORTEX HORMONES; BLOOD GLUCOSE; HUMANS; INTENSIVE CARE UNITS; MONITORING, PHYSIOLOGIC; PARESIS; RISK FACTORS; VENTILATORS, MECHANICAL;

EID: 0842291443     PISSN: 10705295     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075198-200402000-00008     Document Type: Review

References (48)

1. Bolton CF, Gilbert JJ, Fhahn A, Sibbald WJ: Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatr 1984, 47:1223-1231.
2. Couturier J, Robert D, Monier P: Polynévrites compliquant des séjours prolongés en réanimation. Lyon Med 1984, 252:247-249.
3. MacFarlane IA, Rosenthal FD: Severe myopathy after status asthmaticus. Lancet 1977, ii:615.
4. De Jonghe B, Cook D, Sharshar T, et al.: Acquired neuromuscular disorders in critically ill patients: a systematic review. Intensive Care Med 1998, 24:1242-1250.
5. Bolton C, Laverty D, Brown J, et al.: Critically ill polyneuropathy: electrophysiologic studies and differences from Guillain-Barré syndrome. J Neurol Neurosurg Psychiatr 1986, 49:563-573.
6. Helliwell T, Coakley J, Wagenmakers A, Bone J: Necrotizing myopathy in critically-ill patients. J Pathol 1991, 164:307-314.
7. Coakley J: Preliminary observations on the neuromuscular abnormalities in patients with organ failure and sepsis. Intensive Care Med 1993, 19:323-328.
8. Kleyweg RP, van der Meche FG, Meulstee J: Treatment of Guillain-Barre syndrome with high-dose gammaglobulin. Neurology 1988, 38:1639-1641.
9. Kleyweg RP, VanDerMeché FG, Schmitz PI: Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve 1991, 14:1103-1109.
10. Latronico N, Rasulo FA, Recupero D, et al.: Acute quadriplegia with delayed onset and rapid recovery. Case report. J Neurosurg 1998, 88:769-772.
11. Tennila A, Salmi T, Pettila V, et al.: Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis. Intensive Care Med 2000, 26:1360-1363.
12. Sander HW, Golden M, Danon MJ: Quadriplegic areflexic ICU illness: selective thick filament loss and normal nerve histology. Muscle Nerve 2002, 26:499-505. Interesting investigation of ICU-acquired areflexic quadriplegia, evaluating the contribution of axonopathy to the motor deficit.
13. Rich M, Teener J, Raps E, et al.: Muscle is electrically inexcitable in acute quadriplegic myopathy. Neurology 1996, 46:731-735.
14. Rich MM, Bird SJ, Raps EC, et al.: Direct muscle stimulation in acute quadriplegic myopathy. Muscle Nerve 1997, 20:665-673.
15. De Jonghe B, Sharshar T, Lefaucheur JP, et al.: Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 2002, 288:2859-2867. First prospective study of the incidence of weakness at awakening from the acute phase of severe disease in the ICU. Contains a risk factor analysis for significant weakness.
16. Douglass J: Myopathy in severe asthma. Am Rev Respir Dis 1992, 146:517-519.
17. Leijten FS, Harinck-de-Weerd JE, Poortvliet DC, de-Weerd AW: The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. JAMA 1995, 275:442-443.
18. Garnacho-Montero J, Madrazo-Osuna J, Garcia-Garmendia JL, et al.: Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med 2001, 27:1288-1296.
19. Witt NJ, Zochodne DW, Bolton CF: Grand'Maison F, Wells G, Young GB, et al. Peripheral nerve function in sepsis and multiple organ failure. Chest 1991, 99:176-184.
20. van der Schaaf M, Beelen A, de Groot IJ: Critical illness polyneuropathy: a summary of the literature on rehabilitation outcome. Disabil Rehabil 2000, 22:808-810.
21. Herridge MS, Cheung AM, Tansey CM, et al.: One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003, 348:683-693. Exhaustive follow-up of walking ability, pulmonary function, and quality of life after acute respiratory distress syndrome, with a comprehensive risk factor analysis.
22. Fletcher SN, Kennedy DD, Ghosh IR, et al.: Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness. Crit Care Med 2003, 31:1012-1016. Post-ICU investigation of weakness and functional impairment after a prolonged ICU stay, suggesting that the axonal component of the combined nerve and muscle involvement might persist for several years after ICU discharge.
23. DeJonghe B, Cook D, Outin H: Risk factors for polyneuromyopathy of critical illness. In: Yearbook of Intensive Care and Emergency Medicine. Edited by Vincent JL. Berlin, Springer-Verlag; 1999:322-330.
24. Campellone JV, Lacomis D, Kramer DJ, et al.: Acute myopathy after liver transplantation. Neurology 1998, 50:46-53.
25. Bolton C: Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit Care Med 1996, 24:1408-1416.
26. De Letter MA, van Doorn PA, Savelkoul HF, et al.: Critical illness polyneuropathy and myopathy (CIPNM): evidence for local immune activation by cytokine-expression in the muscle tissue. J Neuroimmunol 2000, 106:206-213.
27. Verheul GA, de Jongh-Leuvenink J, Op de Coul AA, et al.: Tumor necrosis factor and interleukin-6 in critical illness polyneuromyopathy. Clin Neurol Neurosurg 1994, 96:300-304.
28. Sassoon CS, Caiozzo VJ, Manka A, Sieck GC: Altered diaphragm contractile properties with controlled mechanical ventilation. J Appl Physiol 2002, 92:2585-2595.
29. Konagaya M, Bernard PA, Max SR: Blockade of glucocorticoid receptor binding and inhibition of dexamethasone-induced muscle atrophy in the rat by RU38486, a potent glucocorticoid antagonist. Endocrinology 1986, 119:375-380.
30. Rich MM, Pinter MJ, Kraner SD, Barchi RL: Loss of electrical excitability in an animal model of acute quadriplegic myopathy. Ann Neurol 1998, 43:171-179.
31. Rich MM, Pinter MJ: Crucial role of sodium channel fast inactivation in muscle fibre inexcitability in a rat model of critical illness myopathy. J Physiol 2003, 547:555-566.
32. Du Bois DC, Almon RR: A possible role for glucocorticoids in denervation atrophy. Muscle Nerve 1981, 4:370-373.
33. Van den Berghe G, Wouters P, Weekers F, et al.: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001, 345:1359-1367.
34. Van den Berghe G, Wouters PJ, Bouillon R, et al.: Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 2003, 3:359-366. Important complementary results of the original study in the New England Journal of Medicine in 2001, suggesting that normoglycemia, rather than the infused insulin dose per se, is related to the favorable outcomes, including the reduced incidence of critical illness polyneuropathy.
35. Segredo V, Caldwell J, Matthay M, et al.: Persistant paralysis in critically ill patients after long-term administration of vecuronium. N Engl J Med 1992, 327:524-528.
36. Leatherman J, Fluegel W, David W, et al.: Muscle weakness in mechanically ventilated patients with severe asthma. Am J Respir Crit Care Med 1996, 153:1686-1690.
37. Behbehani NA, Al-Mane F, D'Yachkova Y, et al.: Myopathy following mechanical ventilation for acute severe asthma: the role of muscle relaxants and corticosteroids. Chest 1999, 115:1627-1631.
38. Adnet F, Dhissi G, Borron SW, et al.: Complication profiles of adult asthmatics requiring paralysis during mechanical ventilation. Intensive Care Med 2001, 27:1729-1736.
39. Brook AD, Ahrens TS, Schaiff R, et al.: Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med 1999, 27:2609-2615.
40. Kress J, Pohlman A, O'Connor M, Hall J: Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 2000, 342:1471-1477.
41. Annane D, Sebille V, Charpentier C, et al.: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002, 288:862-871.
42. Meduri GU, Headley AS, Golden E, et al.: Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1998, 280:159-165.
43. Griffiths RD, Palmer TE, Helliwell T, et al.: Effect of passive stretching on the wasting of muscle in the critically ill. Nutrition 1995, 11:428-432.
44. Horton WA, Fergusson NV: Hyperkalaemia and cardiac arrest after the use of suxamethonium in intensive care. Anaesthesia 1988, 43:890-891.
45. Hemming AE, Charlton S, Kelly P: Hyperkalaemia, cardiac arrest, suxamethonium and intensive care. Anaesthesia 1990, 45:990-991.
46. Dornan RI, Royston D: Suxamethonium-related hyperkalaemic cardiac arrest in intensive care. Anaesthesia 1995, 50:1006.
47. Markewitz BA, Elstad MR: Succinylcholine-induced hyperkalemia following prolonged pharmacologic neuromuscular blockade. Chest 1997, 111:248-250.
48. Hughes M, Grant IS, Biccard B, Nimmo G: Suxamethonium and critical illness polyneuropathy. Anaesth Intensive Care 1999, 27:636-638.